Sage Journals: Discover world-class research

Abstract

Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), involve progressive and irreversible destruction and pathogenic remodeling of airways and have become the leading health care burden worldwide. Pulmonary tissue has extensive capacities to launch injury-responsive repairing programs (IRRPs) to replace the damaged or dead cells upon acute lung injuries. However, the IRRPs are frequently compromised in chronic lung diseases. In this review, we aim to provide an overview of somatic stem cell subpopulations within distal airway epithelium and the underlying mechanisms mediating their self-renewal and trans-differentiation under both physiological and pathological circumstances. We also compared the differences between humans and mice on distal airway structure and stem cell composition. At last, we reviewed the current status and future directions for the development of targeted therapeutics on defective distal airway regeneration and repairment in chronic lung diseases.

Keywords

lung stem cell cell niche chronic lung diseases

Introduction

The lung tissue had been considered highly quiescent with limited regenerative capacities; however, large body of evidences has revealed that the lung tissue possesses remarkable reparative capacities responsive to varieties of distal airway injuries¹. The distal airway comprises terminal bronchioles (TB) and alveoli that perform essential respiratory functions. The bronchioles branch off from a hierarchy of bronchi that are stemmed from the trachea, and the alveoli are the basic units for gas exchange. The distal airway epithelium is composed of a wide variety of epithelial cells^2,3, several of which have been reported as somatic stem cells (SSCs) (Fig. 1).

Figure 1.

The anatomical structures of human and mouse airways and their epithelial components. TB: terminal bronchioles; BADJ: bronchioalveolar duct junctions; BASC: bronchioalveolar stem cells; AT1: alveolar type I; AT2: alveolar type II; RAS: respiratory airway secretory; RB: respiratory bronchioles.

Different SSCs have their own unique niches, including SSCs and their progenies, but also a variety of heterogeneous cell types and extracellular matrix (ECM). Under physiological conditions, SSCs are largely in dormant state, maintaining low level of self-renewal and differentiation. Once the tissue is injured, the SSCs receive signals from surrounding microenvironment that subsequently drive the regeneration or reparative process. However, the reparative capacities of SSCs are frequently compromised if the niche environment is not supportive⁴.

Human and mouse lungs have similar histological structure. The lung is composed of trachea, bronchi, bronchioles, and alveoli from the proximal to the distal airways. Trachea and bronchi are mainly composed of club cells, goblet cells, multiciliated cells, basal cells, and a small number of neuroendocrine cells, brush cells, and ionocytes. Unlike human, mouse small airways do not contain basal cells or goblet cells. The human distal airway is connected to the alveolar through a transitional airway region (also known as the respiratory bronchiole [RB]). In this region, there are rare newly discovered stem cells called respiratory airway secretory (RAS) cells⁵. There are no RB in mice, which directly transit to the alveolar area through the middle airway. The distal bronchioalveolar duct junction (BADJ) region in the mouse lung contains bronchioalveolar stem cell (BASC) population, whose counterparts have not been found in human lung. Both mouse and human alveoli contain two cell populations, alveolar type II (AT2) and alveolar type I (AT1) cells (Table 1).

Table 1.

Identification of Pulmonary Epithelial Stem Cells.

Cell type	Location	Makers	Differentiation repertoire	References
Basal cells	Airways	TRP63, KRT5, NGFR, PDPN	club, ciliated, AT2s	^7,23
Club cells	Airways	SCGB1A1^high, SCGB3A1, SCGB3A2	ciliated, basal, AT2s	^16,17
Variant club cells	NEBs in bronchioles	SCGB1A1, UPK3A	club, ciliated	^19,21
Distal airway stem cells (DASCs)	Distal airways (bronchioles and alveolar regions)	TP63, KRT5	Krt5⁺ “pods”	²³(p. 1),²⁴
Bronchioalveolar stem cells (BASCs)	Bronchioalveolar-duct junctions (mouse)	SFTPC, SCGB1A1	club, AT2s	²⁸
Respiratory airway secretory cells (RASCs)	Respiratory bronchioles (human)	SCGB3A2^high, SCGB1A1	AT1s	⁵
Alveolar type 1 cells (AT1s)	Alveolus	AQP5, PDPN, HOPX, RAGE,	AT2s	^38,42
Alveolar type 2 cells (AT2s)	Alveolus	SFTPC, LAMP3	AT1s	^36,39

Distal Airway SSCs

SSCs in the Bronchi

Basal cells

Human lung basal cells are distributed throughout the main airways to the terminal and respiratory bronchioles (TRB), and owing to the lack of counterpart RB, the mouse basal cells are mainly distributed in the main bronchi only⁶. Basal cells occupy ~6% of the epithelium in the smallest conducting airways and are commonly identified as KRT5⁺TP63⁺ at steady state⁷. Lineage-tracing experiments validated that Krt14⁺ basal cells are multipotent airway progenitors that could give rise to ciliated cells and secretory cell types following naphthalene-induced lung injury (Box 1)^8,9. In vitro sphere-forming assays (Box 2) demonstrated that both human and mouse airway basal cells can self-renew and generate luminal cells⁷. Gene expression analysis and histomorphometric studies with both steady-state and naphthalene-injured mouse trachea have demonstrated that there are two basal cell pools (Krt14⁺ and Krt14⁻) that restore the tracheobronchial epithelium coordinately^10,11. More recently, a study pointed out that NOTCH signaling is required for the differentiation, but not self-renewal of basal cells^12,13. Another study showed that immediately following injury, one p63⁺ basal cell population activates intracellular NOTCH2 signaling and generates secretory cells directly, while the other basal cell population expresses c-Myb and directly yields ciliated cells¹⁴. In addition, a rare population of SOX9⁺/P63⁺/KRT5⁺ basal cells has been shown to be able to regenerate human alveoli¹⁵.

Box 1.

Models of lung injuries.

1. Pneumonectomy (PNX)

Pneumonectomy is an animal model of alveolar regeneration induced by pneumonectomy^135,136. In different species, studies have found that after surgical removal of one or more lobes, compensatory regeneration of the remaining lung tissue induces the formation of new blood vessels, epithelial and mesenchymal cells, and alveolar septum to restore alveolar surface area. Eventually, alveolar stem cells proliferate and differentiate, new pulmonary alveoli regenerate, respiratory function recovers, and respiratory tension in the alveolar area returns to normal physiological levels^40,42,62,71.

2. Bleomycin (BLM)

Bleomycin is an anti-cancer drug. One of the side effects is pulmonary fibrosis. Most studies suggest that the mechanism of BLM-induced pulmonary fibrosis is to induce DNA breaks, produce free radicals, induce oxidative stress, cause cell apoptosis or necrosis, leading to pulmonary inflammation and fibrosis^137,138. At present, bleomycin-induced pulmonary fibrosis animal model is the most widely used experimental model for pulmonary fibrosis^138,139.

3. Naphthalene

Naphthalene is an aromatic hydrocarbon that is used to induce ablation of club cells¹⁸. After naphthalene-induced damage, cytochrome P450-2F2 (CYP-2F2) metabolizes naphthalene to toxic epoxides, and club cells expressing cytochrome P450-2F2 (CYP-2F2) are selectively ablated^19,20. High doses of naphthalene can cause epithelial denuding damage and even lead to loss of surface basal cells^140,141.

4. Elastase

In emphysema, elastase is involved in alveolar wall degradation. Studies have shown that exogenous administration of elastase can cause emphysema¹⁴². The most common method of inducing emphysema is intratracheal instillation of porcine pancreatic elastase (PPE) or human neutrophil elastase (HNE)¹⁴². Intratracheal instillation of large amounts of elastase in mice can lead to alveolar destruction and enlarged air space. Protease-induced emphysema animal model is a commonly used as mature lung injury model at short time expense¹²².

Box 2.

Lung Organoids Culture Models.

1. Airway-liquid interface (ALI)

ALI uses primary bronchial cells or small airway epithelial cells to establish multi-layered mucosal ciliated epithelium to simulate human respiratory epithelium^143,144. In ALI, the basal side of the cell was in contact with the liquid medium, while the apical side of the cell was exposed to air. ALI are often used to identify growth and differentiation factors and to screen drugs for respiratory diseases¹⁴³.

2. Organoids from basal cells

Based on the source of basal cells, organoids of basal cells can be divided into two categories. The organoids derived from tracheal basal cells are called the tracheospheres, while those derived from bronchi or airways are called the bronchospheres¹⁴⁵. Tracheospheres from mouse tracheal basal cells formed spheres with visible lumens within two weeks in Matrigel, with basal cells in the outer layer and club and ciliated cells in the inner layer⁴. Bronchospheres from human bronchial basal cells are more complicated than those from mice and consist of basal cells, club cells, goblet cells and ciliated cells¹⁴⁶.

3. Organoids from club cells

In mouse distal airways, when co-cultured with mesenchymal cells or mouse lung endothelial cells, club cell-derived organoids produce three different types of colonies, including bronchioles, alveoli and bronchioloalveolar colonies⁸⁷.

4. Organoids from alveolar cells

Primary AT2 cells digested and isolated from donor lungs can form alveolar organoids when co-cultured with feeder cells in matrigel¹⁴⁷. The organoids from AT2 cells are composed of two types of epithelial cells. The polarized AT2 cells are on the outside with their basal membrane facing the Matrigel, while the AT1 cells fold toward the inside⁴¹. Recent studies have shown that alveolar organoids in mice and humans can be cultured without feeder cells using chemical media containing factors related to lung development¹⁴⁸.

5. Organoids from pluripotent stem cells

Lung organoids can also be derived from pluripotent stem cells such as embryonic stem cells and iPSCs^149,150.

The PSC-derived lung cells retain the potential to differentiate into each cell type of body. The structure of human lung organoids produced by pluripotent stem cells is similar to that of primary lung, which is composed of proximal airway epithelium, distal alveolar epithelium and other cell types¹⁴⁹.

AT2: alveolar type II; AT1: alveolar type I; iPSCs: induced pluripotent stem cells.

Club cells

With specific expression of the secretoglobins Scgb1a1 and Scgb3a2, club cells are known as predominant progenitors for the maintaining and repair of bronchial epithelium. Genetic lineage tracing study demonstrated that Scgb1a1⁺club cells can self-renew and differentiate into ciliated cells¹⁶. Of note, studies of dioxide-induced injury and influenza viral infection in mice demonstrated that club cells can also dedifferentiate into basal cells when basal cells are ablated¹⁷. However, it remains unclear whether this process also occurs in physiological condition.

Variant club cells

Naphthalene is an aromatic hydrocarbon that is used to induce the ablation of club cells¹⁸. A pollutant-resistant subpopulation of club cells called variant club cells expressing Clara cell secretory protein (CCSP/SCGB1A1) and Upk3a were identified in a study of naphthalene-induced club cell ablation^19,20. This variant club cell subpopulation lacks the expression of cytochrome P450-2F2 (CYP-2F2), which generates highly cytotoxic 1R, 2S-naphthalene epoxide^19,20. Variant club cells normally locate around neuroendocrine bodies (NEBs) and within the BADJs, and these cells can replenish secretory and ciliated cells under both physiological and pathological (club cell ablation) conditions. In addition, variant club cells can also give rise to AT1 and AT2 cells after bleomycin-induced alveolar injury^21,22.

Distal airway stem cells (DASCs)

Emerging number of reports suggest that alternative subsets of distal airway epithelial cells may serve as facultative progenitors and promote regeneration of injured alveolar epithelium. Lineage tracing study revealed that Trp63⁺stem cells originated from the bronchiolar epithelium can be detected in alveolar regions and assemble into Krt5⁺ pods following pulmonary infection of H1N1 influenza virus²³. Kumar et al.²³ defined this facultative progenitor cells as DASCs. Controversially, earlier studies have shown that DASCs can differentiate into AT1, AT2 cells as well as bronchiolar secretory cells following H1N1 infection²⁴. However, subsequent articles showed that DASCs are unable to repair alveolar epithelium after influenza virus infection in mice^25,26.

Bronchioalveolar stem cells

At the BADJs in the mouse, a rare population of stem cells expressing markers of both club cells (Scgb1a1) and AT2 cells (Sftpc) was called BASCs. BASCs are resistant to bronchiolar and alveolar damage and proliferate during epithelium restoration^27–30. However the role of BASCs during lung repair and regeneration in vivo remains controversial: Rawlins et al.¹⁶ concluded that BASCs do not contribute into postnatal maintaining of bronchioles and alveoli; in contrast, recent two studies demonstrated that BASCs could generate the majority of distal lung airway cells including club cells, ciliated cells, AT1, and AT2 cells after bronchiolar damages and rarely contribute to cellular turnover under homeostatic conditions by using lineage-tracing system^31,32. However, the structure of BADJ has not been found in the human lung. Therefore, it is important to confirm whether BASCs or similar cell subsets exist in human lung.

RB cells

Human distal airways contain a unique structure of RB that are absent in mice⁶. RB are frequently injured in several chronic human respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF)³³. Since the mouse lung lacks the structure of RB, it remains one of the least known regions of the human lung. Surprisingly, two back-to-back papers recently revealed that a new lineage of stem cells is present in this mysterious region of humans distal airways^5,34. Morrisey et al. identified a distinct population of RAS cells expressing high SCGB3A2 level. Results of organoid model (Box 2) showed that these RAS cells are unidirectional progenitor cells that can rapidly differentiate into AT2 cells, a process controlled by coordinated NOTCH and Wnt signaling⁵. Using spatial transcriptomics and single-cell profiling of distal airways, Tata et al. identified several novel TRB cell types, including airway-associated LGR5⁺ fibroblasts, TRB-specific alveolar type-0 (AT0) cells, and TRB secretory cells (TRB-SCs). They showed a new differentiation program that AT2 cells transiently acquire an AT0 state from which they can differentiate into either AT1 cells or TRB-SCs. Although more research is needed to unveil how the RB structures and related stem cells impact human lung function and regeneration, these two articles have milestone significance in the field of human alveolar research.

Alveolar SSCs

Pulmonary gas exchange occurs in alveolar sacs lined by two epithelial cell types: AT2 and AT1. AT1 cells are long flat squamous cells covering majority of the gas-exchange alveolar surface, while AT2 cells are small, cuboidal cells secreting surfactants that prevent alveolar collapse^18,19. AT2 cells have been reported as SSCs^35,36. Recently, it has been reported that AT1 cells also have stem cell plasticity during alveolar development and regeneration^37,38 (Fig. 2).

Figure 2.

Trans-differentiation network among somatic stem cells in distal airways. BASC: bronchioalveolar stem cells; AT2: alveolar type II; RAS: respiratory airway secretory; AT1: alveolar type I.

AT2

AT2 cells are the most thoroughly studied alveolar regenerative progenitors to date. After acute lung injury induced by NO₂ exposure in rats, AT2 cells can self-renew and differentiate into AT1 cells^35,36. These data support that AT2 cells are the progenitor cells for AT1 cells in rodents³⁹. Moreover, a medical study first provided evidence that new lung growth occurred in an adult human after a right-sided pneumonectomy (PNX) (Box 1)⁴⁰. Genetic lineage-tracing experiments showed that AT2 cells self-renew and differentiate at a low rate over 1 year. Moreover, when the lung epithelial cells are ablated after injury, the remaining AT2 cells can proliferate rapidly⁴¹. More details on AT2 functioning at the alveolar stem cells will be reviewed in the following section.

AT1

AT1 cells have long been considered as terminally differentiated cells. However, recent studies have shown that AT1 cells also possess stem cell plasticity. In 2015, Jain et al.⁴² discovered that Hopx⁺ AT1 cells proliferated and dedifferentiated into AT2 cells during adult alveolar regeneration after PNX (Box 1), and this process was regulated by tumor growth factor-beta (TGF-β) signaling. Moreover, a subsequent study further explored the changes of AT1 cells at the transcriptome level and found that there are two types of postnatal AT1 cells: Igfbp2⁺ Hopx⁺ and Igfbp2⁻ Hopx⁺ AT1 cells. The findings of this study supported that there is an “immature” period of Igfbp2⁻ Hopx⁺ AT1 cells during the process of AT2-to-AT1 differentiation in alveolar regeneration. The stem cell like “immature” Igfbp2⁻ Hopx⁺ AT1 cells are bidirectional and capable to trans-differentiate into AT2 cells under pathological conditions, while Igfbp2⁺ Hopx⁺ AT1 cells represent the terminally differentiated population of AT1 cells ³⁸. In the latest study, AT1 cells can be reprogrammed into AT2 cells to promote alveolar regeneration after neonatal injury, and this plasticity is retained during alveolar maturation, while the ability of AT2 cells to differentiate into AT1 cells is restricted in the adult mouse lung³⁷. Up to now, understanding of AT1 cell development and heterogeneity is very limited in the field of lung regeneration. Future investigations are needed to validate whether the reported AT1 plasticity can be extrapolated to other species or other lung injury models.

Basal cells, club cells, and AT2s are the main SSCs in distal airways. SSCs transdifferentiate into each other to maintain lung homeostasis under physiological and pathological states.

Repairing Mechanisms for Distal Airways

Acute pulmonary injuries rapidly induce the intrinsic repairing programs of the SSCs to restore the structural and functional homeostasis. In general, majority of our knowledge for repairing mechanisms of distal airways were obtained from studies of acute pulmonary injuries, during which SSC-intrinsic and -extrinsic factors work orchestrally to facilitate balanced self-renewal and differentiation of SSCs.

Alveolar Repairing and Regeneration

Transitional AT2 states and related regulatory signaling pathways during alveolar regeneration

In the alveolar epithelium, only small proportions (~20%) of AT2 are alveolar epithelial progenitor (AEP) cells that are quiet stable during physiological homeostasis⁴³. When acute lung injuries occur, the AEP pool expands rapidly to regenerate the damaged alveolar epithelium by replenishing large number of AT2 and AT1; however, the AEP pool shrinks back to physiological state once the repairing process is accomplished^35,43. The single-cell omics technique has characterized three transitional states of AT2 during the alveolar repairing process: self-renew (proliferating), self-renew cessation (cell cycle arrest), and transdifferentiating (AT2-to-1)⁴⁴. Several groups have coincidentally defined a AT2 state as pre-AT1 transitional state (PATS) or damage-associated transient progenitor (DATP) cells, which shares the similar transcriptomic features as AT1, but its expressions of canonical AT1 markers including Pdpn, Hopx, and Cav-1 are much lower^45,46–48.

Numerous molecular and genetic studies have identified multiple pathways involved in the regulation of alveolar regeneration, including Wnt, FGF, BMP, NOTCH ligands, TGF-β and retinoid acid (RA). Synergistic activation of these signaling pathways occur dynamically and orderly at different stages of the alveolar repair process. The Wnt/β-catenin, FGF/FGFR2 and ETS variant transcription factor 5 (Etv5) signaling facilitate AT2 self-renew but inhibit AT2-to-1 trans-differentiation^35,43,49,50, while BMP signaling promotes AT2-to-1 transdifferentiation⁵¹. For TGF-β signaling, it was initially considered that the autocrine TGF-β1/Smad pathway is important for AT2-to-1 transdifferentiation⁵², further study precisely revealed that TGF-β signaling needs to be temporally upregulated for cell cycle arrest in AT2, but downregulated afterwards for AT2-to-1 trans-differentiation⁴⁴. The NOTCH pathway is activated in AT2 for AT2 proliferation in response to acute injuries, while subsequent expression of Dlk1 is required to temporally modulate NOTCH signaling for AT2-to-1 transition⁵². RA indirectly promote alveolar repair by rejuvenating regenerative fibroblasts⁵³.

Alveolar microenvironment fuels alveolar repair

Wide variety of components in the alveolar niches, such as fibroblasts, endothelial and immune cells, produce and secrete supporting factors such as Wnt ligands, FGF, BMP, NOTCH ligands, TGF-β, RAs, and so on, to cultivate the AEPs to launch the repairing programs in response to injuries (Fig. 3).

Figure 3.

Reparative niche for alveolar regeneration: (A) Pdgfrα⁺ fibroblasts maintain the stemness of AT2 cells by secreting short-range Wnt ligands. PCECs regulate epithelial homeostasis by modulating the expression of HGF and EGF. Macrophages promote alveolar repair by producing inflammatory cytokines (IL-1β and TNF-α) and HGF. Damaged AT2s secrete the “alarmin” molecules IL-33 that in turn activates ILC2s to release IL-13 and IL-5, which indirectly facilitate AT2 proliferation by promoting differentiation of alternately activated macrophages. (B) A transitional AT2-to-1 state exists during alveolar regeneration. Persistence of aberrant AT2-to-1 transient cell state leads to impaired alveolar regeneration. AT2: alveolar type II; PCECs: pulmonary capillary endothelial cells; HGF: hepatocyte growth factor; EGF: epidermal growth factor; IL: Interleukin; TNF-α: tumor necrosis factor alpha; AT1: alveolar type I.

Fibroblasts serve as the main source of the Wnt ligands

Three fibroblast subpopulations are present in the alveoli: retinol-storing Pdgfrα⁺ lipofibroblasts, cytokine-producing stromal fibroblasts, and mechanically contractile myofibroblasts^54–57. The AEPs are located near the single Pdgfrα⁺ lipofibroblast niches, which are essential for alveolar development by secreting short-range Wnt ligands to facilitate AT2 stemness maintaining and also producing RAs and lipids to promote surfactant synthesis in AT2^35,54–57. Persistent or repeated fibroblast activation leads to pathogenic airway remodeling and impaired capacity to produce supporting factors for SSCs regeneration under chronic pathogenic conditions^54,58.

Pulmonary capillary endothelial cells promote lung alveologenesis

Growing evidence has proved that epithelial-vascular interactions are essential for tissue patterning^59,60. Alveolar epithelial cells are surrounded by pulmonary capillary endothelial cells (PCECs)⁶¹. PCECs are not just passive conduits for the delivery of oxygen, but also promote alveologenesis by providing angiocrine growth signals^59,60. Unilateral PNX induce VEGFR2 and FGFR1 activation within PCECs of the remaining lung lobes, leading to increased production of matrix metalloprotease MMP14, which subsequently promotes regenerative alveolarization by releasing epidermal growth factor (EGF)-like ligands⁶². Pulmonary capillaries regulate epithelial morphogenesis by modulating the expression of hepatocyte growth factor (HGF), which is necessary for distal airway development⁶⁰. Besides, endothelial cell derived HGF also indirectly facilitating lung regeneration through suppressing tissue fibrosis by preventing aberrant activation of the NADPH Oxidase 4 (NOX4) in perivascular fibroblasts^63–65. Recent articles have shown that the Car4⁺PCECs receive reparative signals from adjacent AT1 cells during influenza infection induced alveolar revascularization^66,67.

Immune niches for alveolar epithelium cells

Macrophages/monocytes eliminate foreign substances by engulfing pathogens and triggering immune response^68,69. Growing evidence has shown that macrophages and bone marrow-derived monocytes contribute into acute injury-induced airway epithelium regeneration^70–72. Mechanistically, macrophages promote alveolar repair by producing inflammatory cytokines (IL-1β and TNF-α) and growth factors (HGF)^70,73–75. Damaged AT2s secrete the “alarmin” IL-33, which in turn activates group 2 innate lymphoid cells (ILC2s) that release IL-13 and IL-5. The aforementioned type II cytokines indirectly facilitate AT2 expansion by promoting differentiation of alternatively activated macrophages^71,76. Controversially, another study reported that IL-13 disrupts AT2 stem cell activity⁷². Future studies are important for dissecting other immune cell subpopulations that mediate alveolar regeneration.

Regeneration of Bronchi Epithelium

The distal airways mainly contain two types of SSCs, basal cells and club cells, which function cooperatively to maintain distal airway homeostasis and regeneration^8,9,16 (Fig. 4).

Figure 4.

Reparative niche for bronchi epithelium regeneration. MCs: mesenchymal cells; ASMCs: airway smooth muscle cells; IL: interleukin.

NOTCH and TGF-β/BMP/SMAD signals promote basal cell differentiation and pseudostratified epithelium regeneration

Adult KRT5⁺ basal stem cells turnover slowly to maintain airway epithelial integrity during homeostasis⁷⁷. When the airway epithelium is injured, basal cells proliferate rapidly and differentiate into all cell types of pseudostratified epithelium to repair the damaged airways^14,78. Fate determination of basal cell differentiation is controlled by NOTCH signaling pathway. Basal cells tend to differentiate into club cells when NOTCH2 signal is active; otherwise, they differentiate into ciliated cells¹⁴. In addition, activation of the TGF-β/BMP/SMAD signaling pathway promotes basal cell differentiation and luminal regeneration after injury, while inhibition of this signal leads to basal cell hyperplasia⁷⁹.

BMP and NOTCH signals are essential for club stem cell self-renewal

Club cells mainly exist in the noncartilaginous region of the distal airway, especially in the bronchioles. Club cells can self-renew and differentiate into ciliated cells, making club cells the main progenitors for the maintenance and repair of bronchial epithelium¹⁶. BMP and NOTCH are involved in the self-renewal and differentiation of club stem cells. Bmpr1a-mediated nonclassical BMP signaling pathway is essential for the expansion of regenerating club cells⁸⁰. Loss of Bmpr1a, Tak1, or Mapk14 in adult mouse club cells leads to defective bronchial regeneration and repair. Activation of NOTCH signaling can maintain club cell fate and prevent differentiation of club cells into ciliated cells^81,82. p53 deficiency promoted club cell self-renewal⁸³.

Mesenchymal stromal cells regulate bronchi epithelium regeneration

Mesenchymal cells (MCs), in proximity to the SSCs in the distal airways, have been shown to regulate the stemness and differentiation of SSCs through FGF, Hippo, Wnt, NOTCH signaling pathways. Under steady state, MCs maintain basal stem cell status in cartilaginous airways by providing FGF10 to basal cells to inhibit Hippo signal (increase nuclear yap proteins)^84,85, while upon airway injuries, increased expression of FGF10 in airway smooth muscle cells (ASMCs) and Wnt7b in airway epithelium allow basal cells to move into noncartilage-conducted airways for epithelial regeneration⁸⁴. The Wnt ligands produced by MCs do not contribute much to basal cell proliferation under physiological condition but are essential for epithelium repair post injuries⁵⁴. Following pulmonary injuries, MCs produce Wnt ligands to promote proliferation of basal cells, which further secrete Wnt ligands and subsequently regulate ciliated cells generation from basal cells⁵⁴. Similarly, upon airway injury, IL-6 produced by MCs activates STAT3 in basal stem cells, which in turn inhibits NOTCH signaling and promotes basal stem cell differentiation into ciliated cells⁸⁶. LGR6⁺ ASMCs in bronchiolar epithelium can also help club stem cells repair damaged airway epithelium through Wnt-FGF10 signaling⁸⁷. Hedgehog signaling in Scgb1a1⁺ club cells of the distal airways control postnatal lung mesenchyme quiescence and regulates distal airway epithelium homeostasis and regeneration⁸⁸.

MCs maintain basal stem cell status in cartilaginous airways by providing FGF10 to basal cells to inhibit Hippo signal, while upon airway injuries, increased expression of FGF10 in ASMCs and Wnt7b in airway epithelium allow basal cells to move into noncartilage-conducted airways for epithelial regeneration. IL-6 produced by MCs activates STAT3 in basal stem cells, which in turn inhibits NOTCH signaling and promotes basal stem cell differentiation into ciliated cells.

Impaired Injury-Induced Reparative Programs of SSCs in Chronic Lung Diseases

Chronic lung diseases, such as COPD and IPF, involve long-term and irreversible airway destructions and pathogenic airway remodeling, leading to dampened capacities of lung tissue to launch the “injury-induced reparative programs”⁸⁹; however, the underlying mechanisms remain largely unknown. In most cases, the only treatment for chronic lung disease is tissue transplantation, and the 5-year survival rate post transplantation is only 59%⁹⁰. Understanding of causal mechanisms responsible for the impaired reparative programs is of great significance for the development of targeted therapeutics for chronic lung diseases. Currently speaking, it is suggested that the airway SSCs under repeated injury-repair cycles during the development of chronic lung diseases possess exhausted SSCs stemness caused by SSC-intrinsic and extrinsic mechanisms^91,92.

SSC-Intrinsic

Accumulating evidence suggests AT2 cell injury is an early event in the development of chronic lung diseases^93,94. The common features of COPD and IPF are great loss of functional AT2s accompanied with increased AT2s aging and senescence^89,95–98. Genetic studies demonstrate that senescence of AT2s is sufficient to initiate progressive IPF-like pathologies⁹⁹. Abnormal telomerase expression and misfolded surfactant proteins within AT2s are also closely associated with AT2s senescence and apoptosis^100,101. Therefore, elucidating the underlying mechanisms of AT2s senescence is essential for the development of effective therapies for alveolar repair.

Recent studies have shown that persistence of aberrant AT2-to-1 transient cell state controlled by TP53 signaling fails to repair damaged alveoli and plays important roles in the pathologies of IPF^45,46. The AT2-to-1 transitional cells are trapped in the intermediate stage of abnormal differentiation and are incapable to terminally differentiate into AT1 cells in IPF, leading to destroyed alveolar repairment^45,46. The aberrant PATs are characterized by enriched p53 and TGF-β signaling, cell senescence and DNA damage⁴⁵.

SSC-Extrinsic

Functional reparative capacities of SSCs need permissive niche environment, which is frequently compromised in chronic lung diseases. Progress of lung tissue fibrosis and airway remodeling are accompanied with activation of mesenchymal stromal cells and dysregulated lung endothelial cells, which are incapable of producing enough growth factors and cytokines (HGF, FGF7. . .) to facilitate distal airway regeneration and repairment^102–104. Zepp et al.⁵⁴ identified two MC subpopulations in mouse lung tissue: one is mesenchymal alveolar niche cells (MANCs), which secrete FGF7 to promote AT2s regeneration and differentiation upon lung injury; the other is Axin2⁺ myofibrogenic progenitors (AMPs), which tend to proliferate uncontrollably to form fibrotic scars. Lee et al.¹⁰² reported that decreased expression of the thrombospondin 1 (TSP1) by lung endothelial cells suppresses distal airway regeneration.

Therapeutic Strategies for Distal Airway Repair in Chronic Lung Diseases

Development of targeted therapeutics for distal airway regeneration and repairment in chronic lung diseases has been very challenging, and most of the attempts are preliminary and pre-clinical. The general rationale is to rejuvenate SSCs stemness or/and restore the reparative niche environments (Tables 2 and 3, Fig. 5).

Table 2.

Stem Cell Therapy in Preclinical Trials.

Stem cell type	Source	Model	References
AT2s	Rat	Rat, BLM (intratracheal instillation)	¹²⁵
iPSCs	human	Rat, BLM (intratracheal instillation)	¹²⁶
MSCs	Rat	Rat, LPS (intratracheal instillation) + CS-induced	¹²⁷
ESCs	human	Mouse, BLM (intratracheal instillation)	¹²⁸

AT2s: alveolar type II cells; BLM: bleomycin; iPSCs: induced pluripotent stem cells; MSCs: mesenchymal stem cells; ESCs: embryonic stem cells.

Table 3.

Stem Cell Therapy in Clinical Trials.

ClinicalTrials.gov ID	Status	Conditions	Stem cell type	Interventions
NCT00683722	Phase II (completed)	COPD	MSCs	400× 10⁶ cells, intravenous infusions on Days 0, 30, 60, and 90
NCT04047810	Phase I (active, not recruiting)	COPD	MSCs	0.5 to 2 × 10⁶ cells/kg, intravenously once
NCT02745184	Phase II (recruiting)	IPF	LSCs	1 × 10⁶ cells/kg, fiberoptic bronchoscopy
NCT01306513	Phase I (recruiting)	Emphysema	MSCs	Intravenous

COPD: chronic obstructive pulmonary disease; MSCs: mesenchymal stem cells; IPF: idiopathic pulmonary fibrosis; LSCs: lung stem cells.

Figure 5.

Overview of current therapeutic strategies for distal airway repair in chronic lung diseases. SSCs: somatic stem cells; DQ: dasatinib and quercetin; AAV: adeno-associated virus; iPSCs: induced pluripotent stem cells; hESCs: human embryonic stem cells; MSCs: mesenchymal stem cells; LSCs: lung stem cells.

Therapeutic Interventions on SSCs

Antisenescence

SSCs in the distal airways of chronic lung diseases often express aging-related indicators^89,95,96,105, making anti-senescence strategy an attractive option to rescue SSCs stemness. Delivery of telomerase by adeno-associated virus (AAVs) vectors in AT2s increased telomere length and restored regenerative capacity of AT2s in mice with pulmonary fibrosis¹⁰⁶. Senolytic drugs such as dasatinib and quercetin have been shown to delay the progression of pulmonary fibrosis in aged mice and reduce the aging of alveolar epithelial cells and fibroblasts^105,107. The first published clinical trial of Senolytic therapy (dasatinib plus quercetin, DQ) included 14 patients with IPF to evaluate feasibility of implementing a senolytic intervention (ClinicalTrials.gov ID: NCT02874989). DQ therapy had significantly improved the physical functions of the patients, (including 6-min walk distance, 4-m gait speed and chair-stands time). Based on these preliminary data, researchers are planning to carry out larger clinical trials of DQ therapy.

Growth factor applications

We could also induce the distal airway SSCs stemness by supplementing the essential stem cell growth factors and cytokines, whose availabilities are greatly reduced in chronic lung diseases. Exogeneous FGF7 (also known as keratinocyte growth factor) application could promote compensatory lung growth by alveolar proliferation post PNX in mice¹⁰⁸. A randomized controlled phase-I clinic trial showed that intravenous application of FGF7 attenuated alveolar injury in patients with acute respiratory disease syndrome (ARDS)¹⁰⁹. However, FGF7 application did not efficiently ameliorate any of the disease manifestations of ARDS in a phase-II clinical trial¹¹⁰.

Human populations with haplo-insufficiencies for FGF10 have higher incidence to develop COPD,¹¹¹ and FGF10 expression is suppressed in mesenchymal stromal cells from patients with IPF¹⁰³. Rodent studies have proven the therapeutic values of FGF10 in pulmonary epithelial regeneration in various lung disease models, such as bleomycin-induced alveolar injuries¹¹², naphthalene injury,¹¹³ and high-altitude pulmonary edema¹¹⁴. Well-designed clinical trials are needed to demonstrate the curative effects of FGF10 on distal airway regeneration in patients with chronic lung diseases.

Therapeutics Interventions on SSCs Microenvironment

As progress of tissue fibrosis limits the supportive functions of mesenchymal stromal cells to SSCs in distal airways, antifibrotic agents could be instrumental to distal airway epithelium repair. Quercetin induces apoptosis of senescent fibroblasts in aged mice with pulmonary fibrosis¹⁰⁷. Another study used a combination of quercetin and dasatinib (a tyrosine kinase inhibitor, widely known for its role in the treatment of myeloproliferative syndrome) to treat age-related morbidity in mice. The quercetin-dasatinib therapy significantly suppressed lung tissue fibrosis and aging of alveolar epithelial cells in aged mice¹⁰⁵. Navitoclax, a specific inhibitor of anti-apoptotic BCL-2 and BCL-XL, can selectively kill senescent cells in vitro. Navitoclax treatment effectively eliminated radiation-induced senescent fibroblasts and inhibited senescence-associated secretory phenotype (SASP) in mice¹¹⁵.

Growth factors, such as HGF and FGF1/2/7/10, can inhibit lung tissue fibrosis by reducing collagen accumulation in mice with pulmonary fibrosis^{112,116–119}.

All-trans retinoid acid (ATRA) is known as a key regulator of both embryonic lung development and postnatal alveolarization, promoting alveolar septum and lung growth¹²⁰. In vitro, ATRA stimulates human pulmonary angiogenesis and induces lung fibroblast elastin synthesis¹²¹. Preclinical studies using in vivo animal models of emphysema have demonstrated the incredible ability of ATRA to improve the state of emphysema and repair the alveolar structure of emphysema mice¹²². There was another trial showing that ATRA treatment of elastase-induced emphysema (Box 1) mice increased the number of reparative bone marrow-derived cells in the alveoli¹²³. Moreover, a recent study also supports some novel retinoid X receptor (RXRs) agonists as potential therapeutic strategies for the treatment of porcine pancreatic elastase and cigarette smoke extract (CSE)-induced emphysema¹²⁴.

Stem Cell Therapies

Stem cell transplantation has been proposed as an alternative cell therapy for IPF and COPD^125–127. Preclinical studies have shown that induced pluripotent stem cells (iPSCs), human embryonic stem cells (hESCs), mesenchymal stem cells (MSCs), or lung stem cells (LSCs) could be used to treat COPD and IPF^127–129. Transplantation of AT2s into bleomycin-induced IPF mice can reduce collagen deposition, restore pulmonary surfactant protein production, and alleviate the severity of pulmonary fibrosis¹²⁵. Similarly, lung injury was abrogated in bleomycin-induced IPF mice after transplantation of hESCs-derived AT2 cells¹²⁸. IPSCs transplantation into IPF mice could significantly improve the pulmonary functions¹³⁰. Furthermore, IPSCs transplantation bypasses possible ethical concerns and has a broader application prospect in comparison with ESCs. In a cigarette-smoke-stimulated COPD model, intrapulmonary injection of MSCs can alleviate airway inflammation and emphysema by down-regulating COX-2/PGE2 in alveolar macrophages¹³¹.

Challenges and Perspectives

The human respiratory system is anatomically different in details from that of mouse. The human lung has two left lobes and three right lobes, while the mouse lung has one left lobe and four right lobes. In mice, the conducting airway directly transits to the alveoli at the junction of the bronchial alveolar duct, while in humans and other mammals such as ferrets, the proximal airway gradually transitions to the farthest alveolar space through RB and alveolar tubules⁵. The pseudostratified columnar airway epithelium is present in the trachea and mainstem bronchus in mice, while it even extends to the distal bronchioles in human¹³².

The composition and proportion of SSCs within the distal airway epithelium varies between humans and mice. Most of the epithelial in the trachea are ciliated cells in human, but are nonciliated cells in mice¹³³. There are more goblet cells and fewer club cells in human airways than in mice. The newly discovered RAS cells within human-specific RB are absent in mice⁵. The distal BADJ region in the mouse lung contains BASCs population, whose presence has not been determined in human lung³². Since most of our studies and knowledge on lung homeostasis and regeneration are derived from mouse lungs, the differences between human and mouse lung tissues have limited our understanding of molecular and cellular heterogeneity in human lungs and hindered the investigations of pathogenesis of human chronic lung diseases and the development of related targeted therapeutics. We need to find and use other animal models, such as ferrets, whose lung structures and SSCs are closely related to human lungs⁵.

We still know little about the RB, which are particularly vulnerable to damages that are associated with chronic lung diseases. Distal airways are the target region of early injuries during COPD pathogenesis, and RB are the main obstruction sites of COPD^91,134, reminding us of the importance to unveil the pathogenesis of distal airways during early disease stages.

Footnotes

Acknowledgements

The authors would like to express their gratitude to Professor Pixin Ran from Guangzhou National Laboratory and Professor Jiekai Chen from Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences for the constructive comments to the manuscript.

Author Contributions

JW and HX conceived and wrote the manuscript. GP drew the graphics.

Ethical Approval

This study was approved by our Institutional Review Board.

Statement of Human and Animal Rights

This article does not contain any studies with human or animal subjects.

Statement of Informed Consent

There are no human subjects in this article, and informed consent is not applicable.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the National Natural Science Foundation of China (grant no. 32070918), Distinguished Young Scholars in Guangdong Province (grant no. 2022B1515020109), Start-up funding for the Pediatric Research Institute of Guangzhou Women and Children’s Medical Center (grant no. 3001082).

ORCID iDs

Huahua Xu

Guihong Pan

Jun Wang

References

Beers

Morrisey

. The three R’s of lung health and disease: repair, remodeling, and regeneration. J Clin Invest. 2011;121(6):2065–73.

Hogan

BLM

Barkauskas

Chapman

Epstein

Jain

Hsia

CCW

Niklason

Calle

Randell

Rock

, et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell. 2014;15(2):123–38.

Meng

Cui

Peng

. Lung development and regeneration: newly defined cell types and progenitor status. Cell Regen. 2023;12(1):5.

Chacón-Martínez

Koester

Wickström

. Signaling in the stem cell niche: regulating cell fate, function and plasticity. Development. 2018;145(15):dev165399.

Basil

Cardenas-Diaz

Kathiriya

Morley

Carl

Brumwell

Katzen

Slovik

Babu

Zhou

Kremp

, et al. Human distal airways contain a multipotent secretory cell that can regenerate alveoli. Nature. 2022;604(7904):120–26.

Weibel

Gomez

. Architecture of the human lung. Use of quantitative methods establishes fundamental relations between size and number of lung structures. Science. 1962;137(3530):577–85.

Rock

Onaitis

Rawlins

Clark

Xue

Randell

Hogan

BLM

. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci U S A. 2009;106(31):12771–75.

Hong

Reynolds

Watkins

Fuchs

Stripp

. In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations. Am J Physiol Lung Cell Mol Physiol. 2004;286(4):L643–49.

Hong

Reynolds

Watkins

Fuchs

Stripp

. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol. 2004;164(2):577–88.

10.

Cole

Smith

Jenkins

Graham

Reynolds

. Tracheal basal cells. Am J Pathol. 2010;177(1):362–76.

11.

Ghosh

Brechbuhl

Smith

Hicks

Titchner

Runkle

Reynolds

. Context-dependent differentiation of multipotential keratin 14–expressing tracheal basal cells. Am J Respir Cell Mol Biol. 2011;45(2):403–10.

12.

Carraro

Mulay

Yao

Mizuno

Konda

Petrov

Lafkas

Arron

Hogaboam

Chen

Jiang

, et al. Single-cell reconstruction of human basal cell diversity in normal and idiopathic pulmonary fibrosis lungs. Am J Respir Crit Care Med. 2020;202(11):1540–50.

13.

Rock

Gao

Xue

Randell

Kong

Y-Y

Hogan

BLM

. Notch-dependent differentiation of adult airway basal stem cells. Cell Stem Cell. 2011;8(6):639–48.

14.

Pardo-Saganta

Law

Tata

Villoria

Saez

Mou

Zhao

Rajagopal

. Injury induces direct lineage segregation of functionally distinct airway basal stem/progenitor cell subpopulations. Cell Stem Cell. 2015;16(2):184–97.

15.

Dai

Ren

Liu

Han

Cheng

Zhang

Zuo

. Regeneration of functional alveoli by adult human SOX9+ airway basal cell transplantation. Protein Cell. 2018;9(3):267–82.

16.

Rawlins

Okubo

Xue

Brass

Auten

Hasegawa

Wang

Hogan

BLM

. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell. 2009;4(6):525–34.

17.

Tata

Mou

Pardo-Saganta

Zhao

Prabhu

Law

Vinarsky

Cho

Breton

Sahay

Medoff

, et al. Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature. 2013;503(7475):218–23.

18.

Van Winkle

Buckpitt

Nishio

Isaac

Plopper

. Cellular response in naphthalene-induced Clara cell injury and bronchiolar epithelial repair in mice. Am J Physiol. 1995;269(6, pt 1):L800–18.

19.

Hong

Reynolds

Giangreco

Hurley

Stripp

. Clara cell secretory protein–expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol. 2001;24(6):671–81.

20.

Reynolds

Giangreco

Power

Stripp

. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol. 2000;156(1):269–78.

21.

Guha

Deshpande

Jain

Sebastiani

Cardoso

. Uroplakin 3a+ cells are a distinctive population of epithelial progenitors that contribute to airway maintenance and post-injury repair. Cell Rep. 2017;19(2):246–54.

22.

Guha

Vasconcelos

Cai

Yoneda

Hinds

Qian

Dickel

Johnson

Kimura

Guo

, et al. Neuroepithelial body microenvironment is a niche for a distinct subset of Clara-like precursors in the developing airways. Proc Natl Acad Sci U S A. 2012;109(31):12592–97.

23.

Kumar

Yamamoto

Hoe

Wei

Sun

Joo

Dagher

Zielonka

Wang

, et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell. 2011;147(3):525–38.

24.

Zuo

Zhang

Guan

Liew

A-A

Yamamoto

Wang

Lim

Vincent

Lessard

Crum

, et al. P63+Krt5+ distal airway stem cells are essential for lung regeneration. Nature. 2015;517(7536):616–20.

25.

Kanegai

Donne

Gotts

Driver

Amidzic

Lechner

Jones

Vaughan

Chapman

Rock

. Persistent pathology in influenza-infected mouse lungs. Am J Respir Cell Mol Biol. 2016;55(4):613–15.

26.

Yang

Riccio

Schotsaert

Mori

Lee

D-K

García-Sastre

Cardoso

. Spatial-temporal lineage restrictions of embryonic p63+ progenitors establish distinct stem cell pools in adult airways. Developmental Cell. 2018;44(6):752–61.e4.

27.

Giangreco

Reynolds

Stripp

. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol. 2002;161(1):173–82.

28.

Kim

CFB

Jackson

Woolfenden

Lawrence

Babar

Vogel

Crowley

Bronson

Jacks

. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005;121(6):823–35.

29.

Tropea

Leder

Aslam

Lau

Raiser

Lee

J-H

Balasubramaniam

Fredenburgh

Alex Mitsialis

Kourembanas

Kim

. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012;302(9):L829–37.

30.

Zheng

Limmon

Yin

Leung

NHN

Chow

VTK

Chen

. Regeneration of alveolar type I and II cells from Scgb1a1-expressing cells following severe pulmonary damage induced by bleomycin and influenza Bellusci S, editor. PLoS ONE. 2012;7(10):e48451.

31.

Salwig

Spitznagel

Vazquez Armendariz

Khalooghi

Guenther

Herold

Szibor

Braun

. Bronchioalveolar stem cells are a main source for regeneration of distal lung epithelia in vivo. EMBO J. 2019;38(12):e102099.

32.

Liu

Cui

Huang

Yao

Guo

Qin

Yang

Zhang

, et al. Lung regeneration by multipotent stem cells residing at the bronchioalveolar-duct junction. Nat Genet. 2019;51(4):728–38.

33.

Verleden

Tanabe

McDonough

Vasilescu

Wuyts

Piloni

De Sadeleer

Willems

Mai

Hostens

, et al. Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study. Lancet Respir Med. 2020;8(6):573–84.

34.

Kadur Lakshminarasimha Murthy

Sontake

Tata

Kobayashi

Macadlo

Okuda

Conchola

Nakano

Gregory

Miller

Spence

, et al. Human distal lung maps and lineage hierarchies reveal a bipotent progenitor. Nature. 2022;604(7904):111–19.

35.

Nabhan

Brownfield

Harbury

Krasnow

Desai

. Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells. Science. 2018;359(6380):1118–23.

36.

Olajuyin

Zhang

. Alveolar type 2 progenitor cells for lung injury repair. Cell Death Discov. 2019;5:63.

37.

Penkala

Liberti

Pankin

Sivakumar

Kremp

Jayachandran

Katzen

Leach

Windmueller

Stolz

Morley

, et al. Age-dependent alveolar epithelial plasticity orchestrates lung homeostasis and regeneration. Cell Stem Cell. 2021;28(10):1775–89.e5.

38.

Wang

Tang

Huang

Wang

Zhang

Dai

Wang

Cai

, et al. Pulmonary alveolar type I cell population consists of two distinct subtypes that differ in cell fate. Proc Natl Acad Sci U S A. 2018;115(10):2407–12.

39.

Evans

Bils

. Identification of cells labeled with tritiated thymidine in the pulmonary alveolar walls of the mouse. Am Rev Respir Dis. 1969;100(3):372–78.

40.

Butler

Loring

Patz

Tsuda

Yablonskiy

Mentzer

. Evidence for adult lung growth in humans. N Engl J Med. 2012;367(3):244–47.

41.

Barkauskas

Cronce

Rackley

Bowie

Keene

Stripp

Randell

Noble

Hogan

. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. 2013;123(7):3025–36.

42.

Jain

Barkauskas

Takeda

Bowie

Aghajanian

Wang

Padmanabhan

Manderfield

Gupta

, et al. Plasticity of Hopx+ type I alveolar cells to regenerate type II cells in the lung. Nat Commun. 2015;6(1):6727.

43.

Zacharias

Frank

Zepp

Morley

Alkhaleel

Kong

Zhou

Cantu

Morrisey

. Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. Nature. 2018;555(7695):251–55.

44.

Riemondy

Jansing

Jiang

Redente

Gillen

Miller

Spence

Gerber

Hesselberth

Zemans

. Single-cell RNA sequencing identifies TGF-β as a key regenerative cue following LPS-induced lung injury. JCI Insight. 2019;4(8):e123637.

45.

Kobayashi

Tata

Konkimalla

Katsura

Lee

Banovich

Kropski

Tata

. Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis. Nat Cell Biol. 2020;22(8):934–46.

46.

Strunz

Simon

Ansari

Kathiriya

Angelidis

Mayr

Tsidiridis

Lange

Mattner

Yee

Ogar

, et al. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis. Nat Commun. 2020;11(1):3559.

47.

Jiang

Gil

Rubio

Hrycaj

Gurczynski

Riemondy

Moore

Omary

Ridge

Zemans

. Ineffectual type 2–to–type 1 alveolar epithelial cell differentiation in idiopathic pulmonary fibrosis: persistence of the KRT8 hi transitional state. Am J Respir Crit Care Med. 2020;201(11):1443–47.

48.

Choi

Park

J-E

Tsagkogeorga

Yanagita

Koo

B-K

Han

Lee

J-H

. Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration. Cell Stem Cell. 2020;27(3):366–82.e7.

49.

Brownfield

De Arce

Ghelfi

Gillich

Desai

Krasnow

. Alveolar cell fate selection and lifelong maintenance of AT2 cells by FGF signaling. Nat Commun. 2022;13(1):7137.

50.

Zhang

Newton

Kummerfeld

Webster

Kirkpatrick

Phu

Eastham-Anderson

Liu

Lee

, et al. Transcription factor Etv5 is essential for the maintenance of alveolar type II cells. Proc Natl Acad Sci U S A. 2017;114(15):3903–908.

51.

Chung

M-I

Bujnis

Barkauskas

Kobayashi

Hogan

BLM

. Niche-mediated BMP/SMAD signaling regulates lung alveolar stem cell proliferation and differentiation. Development. 2018;145(9):dev163014.

52.

Finn

Sottoriva

Pajcini

Kitajewski

Chen

Zhang

Malik

Liu

. Dlk1-mediated temporal regulation of notch signaling is required for differentiation of alveolar type II to type I cells during repair. Cell Rep. 2019;26(11):2942–54.e5.

53.

Gokey

Snowball

Green

Waltamath

Spinney

Black

Hariri

Perl

. Pretreatment of aged mice with retinoic acid supports alveolar regeneration via upregulation of reciprocal PDGFA signalling. Thorax. 2021;76(5):456–67.

54.

Zepp

Zacharias

Frank

Cavanaugh

Zhou

Morley

Morrisey

. Distinct mesenchymal lineages and niches promote epithelial self-renewal and myofibrogenesis in the lung. Cell. 2017;170(6):1134–48.e10.

55.

Dirami

Massaro

Clerch

Ryan

Reczek

Massaro

. Lung retinol storing cells synthesize and secrete retinoic acid, an inducer of alveolus formation. Am J Physiol Lung Cell Mol Physiol. 2004;286(2):L249–56.

56.

Endale

Ahlfeld

Bao

Chen

Green

Bess

Weirauch

Perl

. Temporal, spatial, and phenotypical changes of PDGFRα expressing fibroblasts during late lung development. Dev Biol. 2017;425(2):161–75.

57.

Green

Endale

Auer

Perl

. Diversity of interstitial lung fibroblasts is regulated by platelet-derived growth factor receptor α kinase activity. Am J Respir Cell Mol Biol. 2016;54(4):532–45.

58.

Plikus

Wang

Sinha

Forte

Thompson

Herzog

Driskell

Rosenthal

Biernaskie

Horsley

. Fibroblasts: origins, definitions, and functions in health and disease. Cell. 2021;184(15):3852–72.

59.

Alvarez

Huang

King

ElZarrad

Yoder

Stevens

. Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity. Am J Physiol Lung Cell Mol Physiol. 2008;294(3):L419–30.

60.

Yamamoto

Jun Yun

Gerber

H-P

Ferrara

Whitsett

. Epithelial–vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis. Dev Biol. 2007;308(1):44–53.

61.

Komarova

Malik

. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol. 2010;72:463–93.

62.

Ding

B-S

Nolan

Guo

Babazadeh

Cao

Rosenwaks

Crystal

Simons

Sato

Worgall

Shido

, et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell. 2011;147(3):539–53.

63.

Cao

Lis

Ginsberg

Chavez

Shido

Rabbany

Fong

Sakmar

Rafii

Ding

. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis. Nat Med. 2016;22(2):154–62.

64.

Hecker

Logsdon

Kurundkar

Bernard

Hock

Meldrum

Sanders

Thannickal

. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med. 2014;6(231):231ra47.

65.

Cao

Sun

Shido

Chen

Luo

Huang

, et al. Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis. Sci Transl Med. 2017;9(405):eaai8710.

66.

Vila Ellis

Cain

Hutchison

Flodby

Crandall

Borok

Zhou

Ostrin

Wythe

Chen

. Epithelial Vegfa specifies a distinct endothelial population in the mouse lung. Dev Cell. 2020;52(5):617–30.e6.

67.

Niethamer

Stabler

Leach

Zepp

Morley

Babu

Zhou

Morrisey

. Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury. eLife. 2020;9:e53072.

68.

Herold

Mayer

Lohmeyer

. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol. 2011;2:65.

69.

Byrne

Mathie

Gregory

Lloyd

. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015;70(12):1189–96.

70.

Hung

Sen

Oniskey

Katzen

Cohen

Vaughan

Nieves

Urisman

Beers

Krummel

Herbert

. Macrophages promote epithelial proliferation following infectious and non-infectious lung injury through a Trefoil factor 2-dependent mechanism. Mucosal Immunol. 2019;12(1):64–76.

71.

Lechner

Driver

Lee

Conroy

Nagle

Locksley

Rock

. Recruited monocytes and type 2 immunity promote lung regeneration following pneumonectomy. Cell Stem Cell. 2017;21(1):120–34.e7.

72.

Glisinski

Schlobohm

Paramore

Birukova

Moseley

Foster

Barkauskas

. Interleukin-13 disrupts type 2 pneumocyte stem cell activity. JCI Insight. 2020;5(1):e131232.

73.

Narasaraju

Phoon

Chow

. MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am J Respir Cell Mol Biol. 2010;42(6):732–43.

74.

Katsura

Kobayashi

Tata

Hogan

BLM

. IL-1 and TNFα contribute to the inflammatory niche to enhance alveolar regeneration. Stem Cell Rep. 2019;12(4):657–66.

75.

Cakarova

Marsh

Wilhelm

Mayer

Grimminger

Seeger

Lohmeyer

Herold

. Macrophage tumor necrosis factor-α induces epithelial expression of granulocyte–macrophage colony-stimulating factor: impact on alveolar epithelial repair. Am J Respir Crit Care Med. 2009;180(6):521–32.

76.

Mohapatra

Van Dyken

Schneider

Nussbaum

Liang

Locksley

. Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis. Mucosal Immunol. 2016;9(1):275–86.

77.

Watson

Rulands

Wilkinson

Wuidart

Ousset

Van Keymeulen

Göttgens

Blanpain

Simons

Rawlins

. Clonal dynamics reveal two distinct populations of basal cells in slow-turnover airway epithelium. Cell Rep. 2015;12(1):90–101.

78.

Montoro

Haber

Biton

Vinarsky

Lin

Birket

Yuan

Chen

Leung

Villoria

Rogel

, et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature. 2018;560(7718):319–24.

79.

Mou

Vinarsky

Tata

Brazauskas

Choi

Crooke

Zhang

Solomon

Turner

Bihler

Harrington

, et al. Dual SMAD signaling inhibition enables long-term expansion of diverse epithelial basal cells. Cell Stem Cell. 2016;19(2):217–31.

80.

Shafiquzzaman

Biswas

Mishina

Liu

. The noncanonical BMP signaling pathway plays an important role in club cell regeneration. Stem Cells. 2020;38(3):437–50.

81.

Tsao

Vasconcelos

Izvolsky

Qian

Cardoso

. Notch signaling controls the balance of ciliated and secretory cell fates in developing airways. Development. 2009;136(13):2297–307.

82.

Morimoto

Liu

Cheng

H-T

Winters

Bader

Kopan

. Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci. 2010;123(2):213–24.

83.

McConnell

Yao

Yeckes

Wang

Selvaggio

Tang

Kirsch

Stripp

. P53 regulates progenitor cell quiescence and differentiation in the airway. Cell Rep. 2016;17(9):2173–82.

84.

Volckaert

Yuan

Chao

C-M

Bell

Sitaula

Szimmtenings

El Agha

Chanda

Majka

Bellusci

Thannickal

, et al. Fgf10-hippo epithelial-mesenchymal crosstalk maintains and recruits lung basal stem cells. Dev Cell. 2017;43(1):48–59.e5.

85.

Volckaert

Campbell

Dill

Minoo

De Langhe

. Localized Fgf10 expression is not required for lung branching morphogenesis but prevents differentiation of epithelial progenitors. Development. 2013;140(18):3731–42.

86.

Tadokoro

Wang

Barak

Bai

Randell

Hogan

BLM

. IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells. Proc Natl Acad Sci U S A. 2014;111(35):E3641–49.

87.

Lee

J-H

Tammela

Hofree

Choi

Marjanovic

Han

Canner

Paschini

Bhang

Jacks

, et al. Anatomically and functionally distinct lung mesenchymal populations marked by Lgr5 and Lgr6. Cell. 2017;170(6):1149–63.e12.

88.

Peng

Frank

Kadzik

Morley

Rathi

Wang

Zhou

Cheng

Morrisey

. Hedgehog actively maintains adult lung quiescence and regulates repair and regeneration. Nature. 2015;526(7574):578–82.

89.

Barnes

Burney

PGJ

Silverman

Celli

Vestbo

Wedzicha

Wouters

EFM

. Chronic obstructive pulmonary disease. Nat Rev Dis Primers. 2015;1(1):15076.

90.

Bos

Vos

Van Raemdonck

Verleden

. Survival in adult lung transplantation: where are we in 2020. Curr Opin Organ Transplant. 2020;25(3):268–73.

91.

Koo

Vasilescu

Booth

Hsieh

Katsamenis

Fishbane

Elliott

Kirby

Lackie

Sinclair

Warner

, et al. Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study. Lancet Respir Med. 2018;6(8):591–602.

92.

Kotton

Morrisey

. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med. 2014;20(8):822–32.

93.

Liang

Zhang

Xie

Liu

Chen

Geng

Kurkciyan

Mena

Stripp

Jiang

Noble

. Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice. Nat Med. 2016;22(11):1285–93.

94.

Selman

Pardo

. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis. Cell Signal. 2020;66:109482.

95.

Huang

Wang

Shi

Zhao

Yuan

Yang

, et al. Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells. Cell. 2020;180(1):107–21.e17.

96.

Reyfman

Walter

Joshi

Anekalla

McQuattie-Pimentel

Chiu

Fernandez

Akbarpour

Chen

C-I

Ren

Verma

, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199(12):1517–36.

97.

Bhandary

Shetty

Marudamuthu

Neuenschwander

Boggaram

Morris

Idell

Shetty

. Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. Am J Pathol. 2013;183(1):131–43.

98.

Liu

Wang

Hua

Cui

Zhang

, et al. The cell cycle inhibitor P21 promotes the development of pulmonary fibrosis by suppressing lung alveolar regeneration. Acta Pharm Sin B. 2022;12(2):735–46.

99.

Yao

Guan

Carraro

Parimon

Liu

Huang

Mulay

Soukiasian

David

Weigt

Belperio

, et al. Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis. Am J Respir Crit Care Med. 2021;203(6):707–17.

100.

Zhong

Zhou

Ann

Minoo

Liu

Banfalvi

Krishnaveni

Dubourd

Demaio

Willis

Kim

, et al. Role of endoplasmic reticulum stress in epithelial–mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. Am J Respir Cell Mol Biol. 2011;45(3):498–509.

101.

Waisberg

Barbas-Filho

Parra

Fernezlian

de Carvalho

Kairalla

Capelozzi

. Abnormal expression of telomerase/apoptosis limits type II alveolar epithelial cell replication in the early remodeling of usual interstitial pneumonia/idiopathic pulmonary fibrosis. Hum Pathol. 2010;41(3):385–91.

102.

Lee

J-H

Bhang

Beede

Huang

Stripp

Bloch

Wagers

Tseng

Y-H

Ryeom

Kim

. Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis. Cell. 2014;156(3):440–55.

103.

Chanda

Kurundkar

Rangarajan

Locy

Bernard

Sharma

Logsdon

Liu

Crossman

Horowitz

De Langhe

, et al. Developmental reprogramming in mesenchymal stromal cells of human subjects with idiopathic pulmonary fibrosis. Sci Rep. 2016;6:37445.

104.

Mammoto

Muyleart

Mammoto

. Endothelial YAP1 in regenerative lung growth through the angiopoietin-Tie2 pathway. Am J Respir Cell Mol Biol. 2019;60(1):117–27.

105.

Childs

Durik

Baker

van Deursen

. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015;21(12):1424–35.

106.

Povedano

Martinez

Serrano

Tejera

Gómez-López

Bobadilla

Flores

Bosch

Blasco

. Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres. eLife. 2018;7:e31299.

107.

Hohmann

Habiel

Coelho

Verri

Jr Hogaboam

. Quercetin enhances ligand-induced apoptosis in senescent idiopathic pulmonary fibrosis fibroblasts and reduces lung fibrosis in vivo. Am J Respir Cell Mol Biol. 2019;60(1):28–40.

108.

Kaza

Kron

Leuwerke

Tribble

Laubach

. Keratinocyte growth factor enhances post-pneumonectomy lung growth by alveolar proliferation. Circulation. 2002;106(12, suppl 1):I120–24.

109.

Shyamsundar

McAuley

Ingram

Gibson

O’Kane

McKeown

Edwards

Taggart

Elborn

Calfee

Matthay

, et al. Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury. Am J Respir Crit Care Med. 2014;189(12):1520–29.

110.

McAuley

Cross

Hamid

Gardner

Elborn

Cullen

Dushianthan

Grocott

Matthay

O’Kane

. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Respir Med. 2017;5(6):484–91.

111.

Klar

Blomstrand

Brunmark

Badhai

Håkansson

Brange

Bergendal

Dahl

. Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary disease. J Med Genet. 2011;48(10):705–709.

112.

Gupte

Ramasamy

Reddy

Lee

Weinreb

Violette

Guenther

Warburton

Driscoll

Minoo

Bellusci

. Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 2009;180(5):424–36.

113.

Volckaert

Dill

Campbell

Tiozzo

Majka

Bellusci

De Langhe

. Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J Clin Invest. 2011;121(11):4409–19.

114.

She

Goolaerts

Shen

Tong

Gao

Song

Bai

. KGF-2 targets alveolar epithelia and capillary endothelia to reduce high altitude pulmonary oedema in rats. J Cell Mol Med. 2012;16(12):3074–84.

115.

Chang

Wang

Shao

Laberge

Demaria

Campisi

Janakiraman

Sharpless

Ding

Feng

Luo

, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med. 2016;22(1):78–83.

116.

Dohi

Hasegawa

Yamamoto

Marshall

. Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis. Am J Respir Crit Care Med. 2000;162(6):2302–307.

117.

Sakamoto

Yazawa

Baba

Sato

Kanegae

Hirai

Saito

Goto

Kurahashi

. Keratinocyte growth factor gene transduction ameliorates pulmonary fibrosis induced by bleomycin in mice. Am J Respir Cell Mol Biol. 2011;45(3):489–97.

118.

Becerril

Pardo

Montaño

Ramos

Ramírez

Selman

. Acidic fibroblast growth factor induces an antifibrogenic phenotype in human lung fibroblasts. Am J Respir Cell Mol Biol. 1999;20(5):1020–27.

119.

Kim

Y-S

Hong

Kim

Y-K

Y-M

Jee

Y-K

. The role of FGF-2 in smoke-induced emphysema and the therapeutic potential of recombinant FGF-2 in patients with COPD. Exp Mol Med. 2018;50(11):1–10.

120.

Chen

Cao

Qian

Shao

Niederreither

Cardoso

. A retinoic acid–dependent network in the foregut controls formation of the mouse lung primordium. J Clin Invest. 2010;120(6):2040–48.

121.

Ng-Blichfeldt

Alçada

Montero

Dean

Griesenbach

Griffiths

Hind

. Deficient retinoid-driven angiogenesis may contribute to failure of adult human lung regeneration in emphysema. Thorax. 2017;72(6):510–21.

122.

Massaro

. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med. 1997;3(6):675–77.

123.

Ishizawa

Kubo

Yamada

Kobayashi

Numasaki

Ueda

Suzuki

Sasaki

. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett. 2004;556(1–3):249–52.

124.

Morichika

Miyahara

Fujii

Taniguchi

Oda

Senoo

Kataoka

Tanimoto

Kakuta

Kiura

Maeda

, et al. A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation. Respir Res. 2019;20(1):2.

125.

Guillamat-Prats

Gay-Jordi

Xaubet

Peinado

Serrano-Mollar

. Alveolar type II cell transplantation restores pulmonary surfactant protein levels in lung fibrosis. J Heart Lung Transplant. 2014;33(7):758–65.

126.

Alvarez-Palomo

Sanchez-Lopez

Moodley

Edel

Serrano-Mollar

. Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis. Stem Cell Res Ther. 2020;11(1):213.

127.

Zhang

W-G

Shi

X-M

S-S

Zhang

Mei

Y-J

Zhang

Z-X

Zhao

J-P

Zhang

H-L

. Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir Res. 2014;15(1):33.

128.

Wang

Morales

Calame

Alcorn

Wetsel

. Transplantation of human embryonic stem cell–derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther. 2010;18(3):625–34.

129.

Zhou

Sun

Matsumoto

Moriyama

Asano

Ajioka

Saijo

. Differentiation of mouse induced pluripotent stem cells into alveolar epithelial cells in vitro for use in vivo. Stem Cells Transl Med. 2014;3(6):675–85.

130.

Soh

Zheng

Li Yeo

Yang

Wong

Zhang

Nichane

Asmat

Wong

, et al. CD166pos subpopulation from differentiated human ES and iPS cells support repair of acute lung injury. Mol Ther. 2012;20(12):2335–46.

131.

Song

X-M

Wang

Guo

X-J

W-G

. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Sci Rep. 2015;5(1):8733.

132.

Ball

Hossain

Padalia

Anatomy, airway. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

133.

Davis

Wypych

. Cellular and functional heterogeneity of the airway epithelium. Mucosal Immunol. 2021;14(5):978–90.

134.

Hogg

Chu

Utokaparch

Woods

Elliott

Buzatu

Cherniack

Rogers

Sciurba

Coxson

Paré

. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–53.

135.

Hsia

Herazo

Fryder-Doffey

Weibel

. Compensatory lung growth occurs in adult dogs after right pneumonectomy. J Clin Invest. 1994;94(1):405–12.

136.

Rannels

. Minireview: compensatory growth of the lung following partial pneumonectomy. Exp Lung Res. 1988;14(2):157–82.

137.

Tanjore

Degryse

Crossno

McConaha

Jones

Polosukhin

Bryant

Cheng

D-S

Newcomb

McMahon

, et al. β-catenin in the alveolar epithelium protects from lung fibrosis after intratracheal bleomycin. Am J Respir Crit Care Med. 2013;187(6):630–39.

138.

Liang

Wang

Chu

Zhu

Liu

Qiu

Zhou

Guan

Xue

Chen

, et al. Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis. Mediators Inflamm. 2013;2013:209179.

139.

El Agha

Moiseenko

Kheirollahi

De Langhe

Crnkovic

Kwapiszewska

Szibor

Kosanovic

Schwind

Schermuly

Henneke

, et al. Two-way conversion between lipogenic and myogenic fibroblastic phenotypes marks the progression and resolution of lung fibrosis. Cell Stem Cell. 2017;20(2):261–73.e3.

140.

Tata

Kobayashi

Chow

Tran

Desai

Massri

McCord

Gunn

Tata

. Myoepithelial cells of submucosal glands can function as reserve stem cells to regenerate airways after injury. Cell Stem Cell. 2018;22(5):668–83.e6.

141.

Lynch

Anderson

Rotti

Tyler

Crooke

Choi

Montoro

Silverman

Shahin

Zhao

Jensen-Cody

, et al. Submucosal gland myoepithelial cells are reserve stem cells that can regenerate mouse tracheal epithelium. Cell Stem Cell. 2018;22(5):653–67.e5.

142.

March

Green

Hahn

Nikula

. Animal models of emphysema and their relevance to studies of particle-induced disease. Inhal Toxicol. 2000;12(suppl 4):155–87.

143.

Randell

Fulcher

O’Neal

Olsen

. Primary epithelial cell models for cystic fibrosis research. Methods Mol Biol. 2011;742:285–310.

144.

Gao

Bali

Randell

Hogan

BLM

. GRHL2 coordinates regeneration of a polarized mucociliary epithelium from basal stem cells. J Cell Biol. 2015;211(3):669–82.

145.

Barkauskas

Chung

M-I

Fioret

Gao

Katsura

Hogan

BLM

. Lung organoids: current uses and future promise. Development. 2017;144(6):986–97.

146.

Hild

Jaffe

. Production of 3-D airway organoids from primary human airway basal cells and their use in high-throughput screening. Curr Protoc Stem Cell Biol. 2016;37:IE.9.1–IE.9.15.

147.

Ali

Zhang

Zhao

Jain

Chang

Komatsu

Zhou

Liang

Matthay

H-L

. Fibrinolytic niche is required for alveolar type 2 cell-mediated alveologenesis via a uPA-A6-CD44+-ENaC signal cascade. Signal Transduct Target Ther. 2021;6(1):97.

148.

Katsura

Sontake

Tata

Kobayashi

Edwards

Heaton

Konkimalla

Asakura

Mikami

Fritch

Lee

, et al. Human lung stem cell-based alveolospheres provide insights into SARS-CoV-2-mediated interferon responses and pneumocyte dysfunction. Cell Stem Cell. 2020;27(6):890–904.e8.

149.

Dye

Hill

Ferguson

Tsai

Y-H

Nagy

Dyal

Wells

Mayhew

Nattiv

Klein

White

, et al. In vitro generation of human pluripotent stem cell derived lung organoids. eLife. 2015;4:e05098.

150.

Huang

Islam

O’Neill

Yang

Chen

Mumau

Green

Vunjak-Novakovic

Bhattacharya

Snoeck

. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol. 2014;32(1):84–91.

Repairing Mechanisms for Distal Airway Injuries and Related Targeted Therapeutics for Chronic Lung Diseases

Abstract

Keywords

Introduction

Distal Airway SSCs

SSCs in the Bronchi

Basal cells

Club cells

Variant club cells

Distal airway stem cells (DASCs)

Bronchioalveolar stem cells

RB cells

Alveolar SSCs

AT2

AT1

Repairing Mechanisms for Distal Airways

Alveolar Repairing and Regeneration

Transitional AT2 states and related regulatory signaling pathways during alveolar regeneration

Alveolar microenvironment fuels alveolar repair

Fibroblasts serve as the main source of the Wnt ligands

Pulmonary capillary endothelial cells promote lung alveologenesis

Immune niches for alveolar epithelium cells

Regeneration of Bronchi Epithelium

NOTCH and TGF-β/BMP/SMAD signals promote basal cell differentiation and pseudostratified epithelium regeneration

BMP and NOTCH signals are essential for club stem cell self-renewal

Mesenchymal stromal cells regulate bronchi epithelium regeneration

Impaired Injury-Induced Reparative Programs of SSCs in Chronic Lung Diseases

SSC-Intrinsic

SSC-Extrinsic

Therapeutic Strategies for Distal Airway Repair in Chronic Lung Diseases

Therapeutic Interventions on SSCs

Antisenescence

Growth factor applications

Therapeutics Interventions on SSCs Microenvironment

Stem Cell Therapies

Challenges and Perspectives

Footnotes

Acknowledgements

Author Contributions

Ethical Approval

Statement of Human and Animal Rights

Statement of Informed Consent

Declaration of Conflicting Interests

Funding

ORCID iDs

References